Format

Send to

Choose Destination
Biomark Med. 2009 Apr;3(2):203-9. doi: 10.2217/bmm.09.8.

The 2nd annual oncology biomarkers conference.

Author information

1
Mosaiques-Diagnostics GmbH, Mellendorfer Strasse 7-9, D-30625 Hannover, Germany. schiffer@mosaiques-diagnostics.com

Abstract

This conference was organized by GTCbio, and the central theme was the lifecycle of a cancer biomarker from discovery, over preclinical and clinical validation, to clinical application phase. The meeting allowed the approximately 100 attendants to gain the knowledge and technologies necessary to use powerful biomarker tools for oncology research activities, provided updates on recent biomarker discoveries by classical or omics strategies and demonstrated a perspective of the downstream processes of biomarker development after the discovery phase. The conference gathered together some of today's leading laboratory researchers, pharmacy and biotech decision-makers, technology companies and clinicians to focus on the uses of biomarkers in the field of oncology research. They spoke on how biomarkers can be used to fast track the development of novel cancer drugs and how prognostic markers can lead towards early detection and treatment in personalized medicine approaches.

PMID:
20477511
DOI:
10.2217/bmm.09.8

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center